FARA Advocates for Effective Inclusion of Children Early in Clinical Trials at Pediatric Inclusion Roundtable

Today, the Pediatric Inclusion Roundtable: Effective Inclusion of Children Early in Clinical Trials meeting brought together stakeholders to discuss pediatric drug development for rare diseases like Friedreich’s ataxia. FARA extends sincere gratitude to all of the speakers, including representatives from FDA, NIH, industry sponsors, and patient advocacy groups. Special thanks to Ron Bartek for spearheading this effort along with Leavitt Partners and all of the speakers, moderators, and participants today.